ncRNA name
hsa-miR-155
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
SOCS6-STAT3 signaling pathway
Cancer name
Breast Cancer
Cancer site
Breast
Treatment type
Chemotherapy
Drug
Tamoxifen
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Up
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Whereas inhibition of miR-155 causes cells to apoptosis and enhances TAM sensitivity.
Tissue resource
human breast cancer tissues with tamoxifen resistance
human breast cancer cell lines MCF7
human breast cancer cell lines SKBR3
Experiment
qRT-PCR,Western blot,Dual-luciferase reporter assay
Institute
Shandong Provincial Hospital
American Type Culture Collection
Country
China
USA
Continent
Asia
Amercia